BioWorld - Sunday, February 15, 2026

exelixis inc.

32 items

university of texas md anderson cancer center

32 items

monthly med-tech financings analysis

32 items

cdk2 inhibitors

32 items

restructuring

32 items

chugai pharmaceutical co. ltd.

32 items

theranostics

32 items

base editing

32 items

2021

32 items

osteosarcoma

32 items

pkmyt1 inhibitors

32 items

innocare pharma ltd.

32 items

dmd

32 items

acquisitions

32 items

gvhd

32 items

who

32 items

ausbiotech

32 items

atherosclerosis

32 items

nk cells

32 items

initial public offerings

32 items